Transcranial Magnetic Stimulation to Improve Speech in Aphasia

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
AphasiaCerebrovascular Stroke
Interventions
DEVICE

Transcranial Magnetic Stimulation, Repetitive

10 rTMS treatments (90% of motor threshold, 20 minutes, at 1 Hz) to specific right hemisphere area of brain cortex; 5 days per week for 2 weeks at the Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; or at the Neurology Department, Hospital of the University of Pennsylvania, Philadelphia, PA.

Trial Locations (3)

02130

VA Boston Healthcare System, Jamaica Plain Campus, Boston University Aphasia Research Center (12-A), 150 So. Huntington Ave., Boston

02215

Berenson-Allen Center for Noninvasive Brain Stimulation, 330 Brookline Ave, Kirstein Bldg., Dept. of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston

19104-4283

Department of Neurology, Hospital of the University of Pennsylvania, 3 W. Gates Bldg., Philadelphia

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

collaborator

Harvard Medical School (HMS and HSDM)

OTHER

collaborator

University of Pennsylvania

OTHER

lead

Boston University

OTHER

NCT00608582 - Transcranial Magnetic Stimulation to Improve Speech in Aphasia | Biotech Hunter | Biotech Hunter